{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "33318035",
  "DateCompleted": {
    "Year": "2021",
    "Month": "09",
    "Day": "28"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "12",
    "Day": "07"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2020",
        "Month": "12",
        "Day": "14"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1158/2159-8290.CD-ND2020-018"
    ],
    "Journal": {
      "ISSN": "2159-8290",
      "JournalIssue": {
        "Volume": "11",
        "Issue": "2",
        "PubDate": {
          "Year": "2021",
          "Month": "Feb"
        }
      },
      "Title": "Cancer discovery",
      "ISOAbbreviation": "Cancer Discov"
    },
    "ArticleTitle": "How Cancer Vaccine Tech Shaped COVID Response.",
    "Pagination": {
      "StartPage": "218",
      "MedlinePgn": "218"
    },
    "Abstract": {
      "AbstractText": [
        "The record-breaking speed of vaccine development in response to the coronavirus outbreak relied in part on manufacturing infrastructure, technology development, and research tools previously built for oncologic products."
      ],
      "CopyrightInformation": "\u00a92021 American Association for Cancer Research."
    },
    "PublicationTypeList": [
      "News"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Cancer Discov",
    "NlmUniqueID": "101561693",
    "ISSNLinking": "2159-8274"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "COVID-19 Vaccines"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Cancer Vaccines"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "complications",
        "virology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "COVID-19 Vaccines"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Cancer Vaccines"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "complications",
        "drug therapy",
        "virology"
      ],
      "DescriptorName": "Neoplasms"
    },
    {
      "QualifierName": [
        "genetics",
        "pathogenicity"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "COVID-19 Drug Treatment"
    }
  ]
}